申请人:Kawasaki Gakuen Educational Foundation
公开号:EP3434783A1
公开(公告)日:2019-01-30
The present invention provides a method for measuring senescence of a test subject, including a step of measuring a level of taurine modification of mitochondrial tRNALeu(UUR) in a biological sample isolated from a test subject, by a reverse transcription reaction from a primer with the tRNALeu(UUR) as a template. In addition, the present invention also provides a senescence determining drug containing a primer containing a base sequence consisting of 10 - 25 bases and complementary to the mitochondrial tRNALeu(UUR). Furthermore, the present invention also provides a senescence determining kit containing a primer containing a base sequence consisting of 10 - 25 bases and complementary to the mitochondrial tRNALeu(UUR) and a reverse transcriptase. Moreover, the present invention also provides an agent for improving a taurine modification rate of mitochondrial tRNALeu(UUR), containing taurine as an active ingredient.
本发明提供了一种测定受试者衰老程度的方法,包括通过以tRNALeu(UUR)为模板的引物进行反转录反应,测定从受试者分离的生物样品中线粒体tRNALeu(UUR)的牛磺酸修饰水平的步骤。此外,本发明还提供了一种衰老测定药物,其引物含有 10-25 个碱基序列,并与线粒体 tRNALeu(UUR)互补。此外,本发明还提供了一种衰老测定试剂盒,该试剂盒含有含有由 10 - 25 个碱基组成的碱基序列并与线粒体 tRNALeu(UUR)互补的引物和逆转录酶。此外,本发明还提供了一种提高线粒体 tRNALeu(UUR)牛磺酸修饰率的药剂,其中含有牛磺酸作为活性成分。